The proposed University of Maryland, Baltimore (UMB) CCHI Administrative Core will be responsible for overall organization, management, decision-making, and periodic evaluation of the research projects, technology development projects, training programs, and cores within the UMB CCHI Center. The Core will also be responsible for data sharing, protection of intellectual property, and allocation of UMC CCHI resources. The main focus of the Administrative Core is successful implementation of the program goals to support basic and translational research on human immunological responses to NIAID Category A, B or C priority pathogens, their toxins, or other emerging or re-emerging infectious diseases, and to maintain a stable, flexible, yet centralized infrastructure to promote and coordinate multi-disciplinary research in human immunology as it relates to defense against these agents. The responsibilities of the CCHI Administrative Core will include, but are not limited to: 1) facilitating communications amongst the research, technology and pilot project leaders, scientific cores, and Principal Investigator;2) scheduling group meetings, and conferences;3) organizing presentations and publication of data;4) allocating and reallocating resources to meet program goals;and 5) tracking and prioritizing fiscal and other resources. A key factor in the success of any diverse program of this nature is maintaining continuous communication among the leadership team, investigators, administration, and NIH. The CCHI will interact on a daily basis to enhance communications with CCHI researchers, core leaders, and administrative and financial counterparts at all sites within the UMB CCHI. The core will also be responsible for resource sharing and transmission of information and reagents, management of the budget for programrelated travel (including travel for the annual meetings) and identifying and resolving problems and unexpected outcomes. The Core will also create and implement administrative and leadership mechanisms that will foster effective interactions among the CCHI investigators and institutions to ensure a productive research effort

Public Health Relevance

The main focus of the Administrative Core is successful implementation of the program goals to support basic and translational research on human immunological responses to NIAID Category A, B or C priority pathogens, their toxins, or other emerging or re-emerging infectious diseases, and to maintain a stable, flexible, yet centralized infrastructure to promote and coordinate multi-disciplinary research in human immunology as it relates to defense against these agents.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Program--Cooperative Agreements (U19)
Project #
5U19AI082655-04
Application #
8378492
Study Section
Special Emphasis Panel (ZAI1-KS-I)
Project Start
Project End
Budget Start
2012-06-01
Budget End
2013-05-31
Support Year
4
Fiscal Year
2012
Total Cost
$298,772
Indirect Cost
$93,450
Name
University of Maryland Baltimore
Department
Type
DUNS #
188435911
City
Baltimore
State
MD
Country
United States
Zip Code
21201
Haney, Douglas J; Lock, Michael D; Gurwith, Marc et al. (2018) Lipopolysaccharide-specific memory B cell responses to an attenuated live cholera vaccine are associated with protection against Vibrio cholerae infection. Vaccine 36:2768-2773
Davis, Courtney L; Wahid, Rezwanul; Toapanta, Franklin R et al. (2018) A clinically parameterized mathematical model of Shigella immunity to inform vaccine design. PLoS One 13:e0189571
Toapanta, Franklin R; Bernal, Paula J; Kotloff, Karen L et al. (2018) T cell mediated immunity induced by the live-attenuated Shigella flexneri 2a vaccine candidate CVD 1208S in humans. J Transl Med 16:61
Zhang, Yan; Brady, Arthur; Jones, Cheron et al. (2018) Compositional and Functional Differences in the Human Gut Microbiome Correlate with Clinical Outcome following Infection with Wild-Type Salmonella enterica Serovar Typhi. MBio 9:
Senger, Stefania; Ingano, Laura; Freire, Rachel et al. (2018) Human Fetal-Derived Enterospheres Provide Insights on Intestinal Development and a Novel Model to Study Necrotizing Enterocolitis (NEC). Cell Mol Gastroenterol Hepatol 5:549-568
Sztein, Marcelo B (2018) Is a Human CD8 T-Cell Vaccine Possible, and if So, What Would It Take? CD8 T-Cell-Mediated Protective Immunity and Vaccination against Enteric Bacteria. Cold Spring Harb Perspect Biol 10:
Salerno-Gonçalves, Rosângela; Tettelin, Hervé; Lou, David et al. (2017) Use of a novel antigen expressing system to study the Salmonella enterica serovar Typhi protein recognition by T cells. PLoS Negl Trop Dis 11:e0005912
Booth, Jayaum S; Patil, Seema A; Ghazi, Leyla et al. (2017) Systemic and Terminal Ileum Mucosal Immunity Elicited by Oral Immunization With the Ty21a Typhoid Vaccine in Humans. Cell Mol Gastroenterol Hepatol 4:419-437
Fresnay, Stephanie; McArthur, Monica A; Magder, Laurence S et al. (2017) Importance ofSalmonellaTyphi-Responsive CD8+ T Cell Immunity in a Human Typhoid Fever Challenge Model. Front Immunol 8:208
Salerno-Goncalves, Rosângela; Luo, David; Fresnay, Stephanie et al. (2017) Challenge of Humans with Wild-type Salmonella enterica Serovar Typhi Elicits Changes in the Activation and Homing Characteristics of Mucosal-Associated Invariant T Cells. Front Immunol 8:398

Showing the most recent 10 out of 59 publications